NCT00056823View on ClinicalTrials.gov

Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

December 31, 2005

Conditions
Age-Related Maculopathy
Interventions
DRUG

rhuFab V2 (ranibizumab)

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY